
浏览全部资源
扫码关注微信
陆军军医大学(第三军医大学)第二附属医院病理科,重庆
郭乔楠,E-mail:qiaonan85@263.net
收稿:2025-08-04,
修回:2025-10-14,
录用:2025-10-16,
纸质出版:2025-10-30
移动端阅览
付万垒,郝翔麟,曹亚,等.MiR-616在骨肉瘤中的表达及其对细胞增殖、凋亡、迁移侵袭的作用[J].陆军军医大学学报,2025,47(20):2461-2473.DOI:10.16016/j.2097-0927.202508009.
FU W L,HAO X L,CAO Y,et al.Expression of miR-616 in osteosarcoma and its role in proliferation, apoptosis, migration and invasion of tumor cells[J].J Army Med Univ,2025,47(20):2461-2473.DOI:10.16016/j.2097-0927.202508009.
付万垒,郝翔麟,曹亚,等.MiR-616在骨肉瘤中的表达及其对细胞增殖、凋亡、迁移侵袭的作用[J].陆军军医大学学报,2025,47(20):2461-2473.DOI:10.16016/j.2097-0927.202508009. DOI:
FU W L,HAO X L,CAO Y,et al.Expression of miR-616 in osteosarcoma and its role in proliferation, apoptosis, migration and invasion of tumor cells[J].J Army Med Univ,2025,47(20):2461-2473.DOI:10.16016/j.2097-0927.202508009. DOI:
目的
2
阐释miR-616对骨肉瘤恶性生物学进程的影响,并初步探索其可能机制。
方法
2
采用原位杂交法(ISH)分析2018年1月至2019年12月陆军军医大学第二附属医院病理科11例骨肉瘤石蜡标本中miR-616表达;采用qRT-PCR比较成骨细胞hFOB1.19和骨肉瘤细胞系143B、HOS中miR-616的表达;通过慢病毒转染法构建miR-616敲低和过表达稳定细胞系,将细胞分为miR-616过表达组、过表达对照组、miR-616 敲低组和敲低对照组。采用流式细胞术检测各组细胞增殖和凋亡情况,采用Transwell和平板克隆形成实验检测各组细胞的侵袭和迁移情况。将10只4周龄雌性裸鼠(18~20 g)采用随机数字表法分为对照组和miR-616过表达组,采用皮下动物荷瘤实验比较两组移植瘤生长情况;采用二代测序和双萤光素酶报告系统确定miR-616的靶基因。
结果
2
ISH结果显示,与人骨肉瘤癌旁组织比较,miR-616在骨肉瘤组织中表达增高,主要存在于细胞质中,qRT-PCR结果表明miR-616在骨肉瘤细胞系143B、HOS中均高于成骨细胞hFOB1.19(
P
<
0.05)。体外实验表明,与过表达对照组比较,过表达miR-616组143B和HOS细胞的增殖能力增强(
P
<
0.01),凋亡抑制(
P
<
0.01),迁移能力增强(
P
<
0.01),侵袭能力增加(
P
<
0.01);相反,敲低miR-616后,与敲低对照组比较,miR-616敲低组143B和HOS细胞增殖能力减弱(
P
<
0.05),迁移力减弱(
P
<
0.05),侵袭能力下降(
P
<
0.05),且miR-616-3p对骨肉瘤
的凋亡影响强于miR-616-5p。动物实验表明,过表达miR-616组的小鼠移植瘤质量(98.00±17.22)mg大于对照组(33.60±8.08)mg(
P
<
0.01)。二代测序和双荧光素酶报告系统结果显示,miR-616的靶蛋白为KLF2。
结论
2
miR-616可促进骨肉瘤恶性生物学行为发展,其表达水平可能成为骨肉瘤潜在治疗的靶点。
Objective
2
To elucidate the effects of miR-616 on the malignant biological processes of osteosarcoma and to preliminarily explore its potential mechanisms.
Methods
2
In situ
hybridization (ISH) was employed to analyze miR-616 expression in 11 paraffin-embedded osteosarcoma specimens collected in our department during January 2018 to December 2019. Quantitative real-time PCR (qRT-PCR) was used to compare the mRNA expression level of miR-616 in the osteoblast cell line hFOB1.19 and osteosarcoma cell lines 143B and HOS. Stable cell lines with miR-616 knockdown or overexpression were established
via
lentiviral transfection in 143B and HOS cells. Cell proliferation and apoptosis were detected by flow cytometry
while cell invasion and migration were assessed using Transwell and colony formation assays
respectively. To evaluate the effect of miR-616 on tumor growth in
vivo
10 female nude mice (4 weeks old
weighing 18~20 g) were randomized into a control group and a miR-616 overexpression group. After the xenograft tumor model was constructed
the growth of subcutaneous tumors was monitored. Finally
next-generation sequencing and a dual-luciferase reporter assay were performed to identify the target genes of miR-616.
Results
2
ISH results showed that miR-616 expression was up-regulated in osteosarcoma tissues than adjacent tissues
and primarily localized in the cytoplasm. qRT-PCR confirmed that miR-616 level was significantly higher in 143B and HOS cells than hFOB1.19 cells (
P
<
0.05).
In vitro
experiments revealed that miR-616 overexpression enhanced the prol
iferation
migration and invasion
while suppressing apoptosis in 143B and HOS cells (
P
<
0.01). Conversely
miR-616 knockdown weakened these malignant phenotypes (
P
<
0.05)
with miR-616-3p showing a stronger effect on apoptosis than miR-616-5p. Animal experiments demonstrated that the tumor weight in the miR-616 overexpression group was significantly greater than that of the control group (98.00±17.22
vs
33.60±8.08 mg
P
<
0.01). Furthermore
KLF2 was identified and confirmed as a direct target of miR-616.
Conclusion
2
MiR-616 promotes malignant biological behaviors in osteosarcoma
and its expression level indicates that it may serve as a potential therapeutic target.
ZHANG C , WU H X , XU G J , et al . Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China [J]. BMC Cancer , 2023 , 23 ( 1 ): 506 . DOI: 10.1186/s12885-023-11024-9 http://dx.doi.org/10.1186/s12885-023-11024-9 .
ISAKOFF M S , BIELACK S S , MELTZER P , et al . Osteosarcoma: current treatment and a collaborative pathway to success [J]. J Clin Oncol , 2015 , 33 ( 27 ): 3029 - 3035 . DOI: 10.1200/JCO.2014.59.4895 http://dx.doi.org/10.1200/JCO.2014.59.4895 .
MISHRA P J . microRNAs as promising biomarkers in cancer diagnostics [J]. Biomark Res , 2014 , 2 : 19 . DOI: 10.1186/2050-7771-2-19 http://dx.doi.org/10.1186/2050-7771-2-19 .
DEY M , SKIPAR P , BARTNIK E , et al . microRNA signatures in osteosarcoma: diagnostic insights and therapeutic prospects [J]. Mol Cell Biochem , 2025 , 480 ( 4 ): 2065 - 2075 . DOI: 10.1007/s11010-024-05135-5 http://dx.doi.org/10.1007/s11010-024-05135-5 .
杨美菊 , 武壮壮 , 申振 , 等 . 调节骨肉瘤的微小RNA研究进展 [J]. 中华实验外科杂志 , 2021 , 38 ( 7 ): 1386 - 1391 .
YANG M J , WU Z Z , SHEN Z , et al . Research progress of microRNA regulating osteosarcoma [J]. Chin J Exp Surg , 2021 , 38 ( 7 ): 1386 - 1391 .
李宏维 , 叶凯山 , 王栓科 . 外源性BMP9对骨肉瘤细胞MG63的影响与Wnt/β-catenin信号通路的关系 [J]. 第三军医大学学报 , 2015 , 37 ( 7 ): 655 - 659 . DOI: 10.16016/j.1000-5404.201409140 http://dx.doi.org/10.16016/j.1000-5404.201409140 .
LI H W , YE K S , WANG S K . Effect of exogenous BMP9 on osteosarcoma MG63 cells and its relationship with Wnt/β-catenin signaling pathway [J]. J Third Mil Med Univ , 2015 , 37 ( 7 ): 655 - 659 . DOI: 10.16016/j.1000-5404.201409140 http://dx.doi.org/10.16016/j.1000-5404.201409140 .
ABDOLVAND M , CHERMAHINI Z M , BAHALOO S , et al . New long noncoding RNA biomarkers and CeRNA networks on miR-616-3p in colorectal cancer: Bioinformatics-based study [J]. J Res Med Sci , 2024 , 29 ( 1 ): 10 . DOI: 10.4103/jrms.jrms_786_22 http://dx.doi.org/10.4103/jrms.jrms_786_22 .
ZHANG S S , XU M A , SHEN X F , et al . Up-regulated miR-616-5p promotes the progression of nasopharynx cancer through GSK3β [J]. Tohoku J Exp Med , 2025 , 266 ( 4 ): 353 - 360 . DOI: 10.1620/tjem.2024.j131 http://dx.doi.org/10.1620/tjem.2024.j131 .
ARABKARI V , SULTANA A , BARUA D , et al . UPR-induced miR-616 inhibits human breast cancer cell growth and migration by targeting c-MYC [J]. Int J Mol Sci , 2023 , 24 ( 17 ): 13034 . DOI: 10.3390/ijms241713034 http://dx.doi.org/10.3390/ijms241713034 .
WANG D X , ZOU Y J , ZHUANG X B , et al . Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways [J]. Acta Pharmacol Sin , 2017 , 38 ( 2 ): 241 - 251 . DOI: 10.1038/aps.2016.122 http://dx.doi.org/10.1038/aps.2016.122 .
KELLY A D , HAIBE-KAINS B , JANEWAY K A , et al . microRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32 [J]. Genome Med , 2013 , 5 ( 1 ): 2 . DOI: 10.1186/gm406 http://dx.doi.org/10.1186/gm406 .
SCUDERI S A , CALABRESE G , PATERNITI I , et al . The biological function of microRNAs in bone tumors [J]. Int J Mol Sci , 2022 , 23 ( 4 ): 2348 . DOI: 10.3390/ijms23042348 http://dx.doi.org/10.3390/ijms23042348 .
JIANG M Y , JIKE Y , LIU K C , et al . Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1 [J]. Mol Cancer , 2023 , 22 ( 1 ): 113 . DOI: 10.1186/s12943-023-01804-z http://dx.doi.org/10.1186/s12943-023-01804-z .
EBRAHIMI N , ASLANI S , BABAIE F , et al . microRNAs implications in the onset, diagnosis, and prognosis of osteosarcoma [J]. Curr Mol Med , 2021 , 21 ( 7 ): 573 - 588 . DOI: 10.2174/1566524020999201203212824 http://dx.doi.org/10.2174/1566524020999201203212824 .
RAM KUMAR R M , BORO A , FUCHS B . Involvement and clinical aspects of microRNA in osteosarcoma [J]. Int J Mol Sci , 2016 , 17 ( 6 ): 877 . DOI: 10.3390/ijms17060877 http://dx.doi.org/10.3390/ijms17060877 .
XIE L , LI W , LI Y . miR-744-5p inhibits cell growth and angiogenesis in osteosarcoma by targeting NFIX [J]. J Orthop Surg Res , 2024 , 19 ( 1 ): 485 . DOI: 10.1186/s13018-024-04947-x http://dx.doi.org/10.1186/s13018-024-04947-x .
GONG Y B , WEI Z R . miR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1 [J]. BMC Cancer , 2022 , 22 ( 1 ): 934 . DOI: 10.1186/s12885-022-10029-0 http://dx.doi.org/10.1186/s12885-022-10029-0 .
LUO X L , DAI X Y , WEI Q S , et al . microRNA-767-5p promotes metastasis but improves chemotherapeutic and radiotherapeutic sensitivity of osteosarcoma [J]. BMC Cancer , 2025 , 25 ( 1 ): 702 . DOI: 10.1186/s12885-025-14114-y http://dx.doi.org/10.1186/s12885-025-14114-y .
MISHRA S , YADAV T , RANI V . Exploring miRNA based approaches in cancer diagnostics and therapeutics [J]. Crit Rev Oncol , 2016 , 98 : 12 - 23 . DOI: 10.1016/j.critrevonc. 2015.10.003 http://dx.doi.org/10.1016/j.critrevonc.2015.10.003 .
MEDINA-CALZADA Z , JING R C , MOXON S , et al . An intron-split microRNA mediates cleavage of the mRNA encoded by low phosphate root in Solanaceae [J]. Planta , 2025 , 261 ( 2 ): 27 . DOI: 10.1007/s00425-024-04596-8 http://dx.doi.org/10.1007/s00425-024-04596-8 .
GUO L , REN D K , ZHANG Y T , et al . A comprehensive pan-cancer analysis reveals cancer-associated robust isomiR expression landscapes in miRNA arm switching [J]. Mol Genet Genomics , 2023 , 298 ( 3 ): 521 - 535 . DOI: 10.1007/s00438-023-01997-4 http://dx.doi.org/10.1007/s00438-023-01997-4 .
MITRA R , ADAMS C M , JIANG W , et al . Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival [J]. Nat Commun , 2020 , 11 ( 1 ): 968 . DOI: 10.1038/s41467-020-14713-2 http://dx.doi.org/10.1038/s41467-020-14713-2 .
张敏 , 李敏 , 肖猛 , 等 . miR-543/SNTB1轴调控结直肠癌免疫微环境 [J]. 陆军军医大学学报 , 2025 , 47 ( 13 ): 1484 - 1493 . DOI: 10.16016/j.2097-0927.202504078 http://dx.doi.org/10.16016/j.2097-0927.202504078 .
ZHANG M , LI M , XIAO M , et al . miR-543/SNTB1 axis modulates immune microenvironment in colorectal cancer [J]. J Army Med Univ , 2025 , 47 ( 13 ): 1484 - 1493 . DOI: 10.16016/j.2097-0927.202504078 http://dx.doi.org/10.16016/j.2097-0927.202504078 .
REN W B , HU J , LI H H , et al . miR-616-5p promotes invasion and migration of bladder cancer via downregulating NR2C2 expression [J]. Front Oncol , 2021 , 11 : 762946 . DOI: 10.3389/fonc.2021.762946 http://dx.doi.org/10.3389/fonc.2021.762946 .
TAVARES V , SAVVA-BORDALO J , REI M , et al . Plasma microRNA environment linked to tissue factor pathway and cancer-associated thrombosis: prognostic significance in ovarian cancer [J]. Biomolecules , 2024 , 14 ( 8 ): 928 . DOI: 10.3390/biom14080928 http://dx.doi.org/10.3390/biom14080928 .
刘欣 , 许秋然 , 张美齐 , 等 . microRNA-616在肝细胞癌侵袭转移中的作用机制研究 [J]. 浙江医学 , 2017 , 39 ( 12 ): 979 - 983, 989 .
LIU X , XU Q R , ZHANG M Q , et al . Expression of miR-616 in human hepatocellular carcinoma and its effect on tumor invasion and metastasis [J]. Zhejiang Med J , 2017 , 39 ( 12 ): 979 - 983, 989 .
ZHENG S N , QIAN Z Y , JIANG F , et al . CircRNA LRP6 promotes the development of osteosarcoma via negatively regulating KLF2 and APC levels [J]. Am J Transl Res , 2019 , 11 ( 7 ): 4126 - 4138 .
RUAN J W , ZHENG L L , HU N , et al . Long noncoding RNA SNHG6 promotes osteosarcoma cell proliferation through regulating p21 and KLF2 [J]. Arch Biochem Biophys , 2018 , 646 : 128 - 136 . DOI: 10.1016/j.abb. 2018. 03.036 http://dx.doi.org/10.1016/j.abb.2018.03.036 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621